| Nov 7 |
AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)
|
| Nov 7 |
Unveiling Astrazeneca (AZN) Q3 Outlook: Wall Street Estimates for Key Metrics
|
| Nov 7 |
AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024
|
| Nov 7 |
Q3 2024 Ionis Pharmaceuticals Inc Earnings Call
|
| Nov 6 |
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
|
| Nov 6 |
China Has Detained Senior AstraZeneca Executive
|
| Nov 6 |
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
|
| Nov 6 |
AstraZeneca’s top China executive detained by authorities
|
| Nov 6 |
Top AstraZeneca Executives Caught in Expanding China Probe, Shares Slide Further
|
| Nov 6 |
AstraZeneca extends losses as Chinese probe widens
|
